Indoor environment assessment to help manage fibrosing hypersensitivity pneumonitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults with fibrosing hypersensitivity pneumonitis identified through multidisciplinary discussions. The indoor environment medical advisor conducts home environmental audits, collects swabs, and places a sensor for four weeks to identify potential antigen exposures. Serum precipitins are measured after antigens are identified, and follow-up calls/visits assess whether removing exposures reduces antigen presence over 6 and 12 months. The study relies on routine care pathways with no specified experimental interventions beyond standard CMEI activities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient of legal age,
* French-speaking patient,
* Patient with a diagnosis of fibrosing PHS following a multidisciplinary discussion of diffuse interstitial lung disease hypersensitivity pneumonitis .
* Patient who had received an information note presenting the study and who had not expressed opposition to participating in this research.

Exclusion Criteria:

* Opposition of the patient to participate in the study,
* Patient under guardianship, curatorship or safeguard of justice,
* Patients who have moved within the last 12 months, or who plan to move within the next 6 months,
* Patients who have already had a visit from the indoor environment medical advisor.

Where it's running

• CHU de Nantes
  Nantes, Loire-Atlantique, France Recruiting
• CHU Angers
  Angers, France Recruiting
• Chd Lrsy
  La Roche-sur-Yon, France Recruiting
• CH Cote de lumière
  Les Sables-d'Olonne, France Recruiting
• CH St Nazaire
  Saint-Nazaire, France Recruiting
• CH Ancenis
  Ancenis, France Not yet recruiting

Study contacts

• Principal investigator: Stéphanie DIROU, PH — Nantes University Hospital
• Study coordinator: Stéphanie DIROU, PH
• Email: stéphanie.dirou@chu-nantes.fr
• Phone: +33 2 53 48 27 74

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving quality of life for patients with hypersensitivity pneumonitis

  This study is testing a new support program that uses peer coaching to help people with hypersensitivity pneumonitis feel better and understand their condition more clearly.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT06811389

• Database and biobank for patients with hypersensitivity pneumonitis

  This study is collecting blood samples and health information from people with hypersensitivity pneumonitis to see how they compare to those with idiopathic pulmonary fibrosis and to help find better ways to diagnose and understand their condition.

  Recruiting University Hospital, Gentofte, Copenhagen · Hellerup, Copenhagen · NCT05549635

• Biobank for interstitial lung diseases

  This study is setting up a collection of health information and samples from patients with interstitial lung diseases to help researchers learn more about the condition and find better treatments.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT05392881

• Examining muscle function in patients with interstitial lung disease

  This study tests how muscle function affects breathing and exercise in people with interstitial lung disease compared to healthy individuals, and looks at how supplemental oxygen might help.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT03800017

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.